Showing results (41-50 of 1,275) with videos related to
Sort By:
Pageof 128
Seminars in Nuclear Medicine|February 13, 2002
Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disordersAndrew Newberg, Abass Alavi, Martin ReivichJournal of Alzheimer'S Disease : JAD|October 18, 2021
Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging DataPoul F Høilund-Carlsen, Abass AlaviNuclear Medicine Communications|March 5, 2008
Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient managementSandip Basu, Mohamed Houseni, Abass AlaviSeminars in Nuclear Medicine|February 13, 2002
Whole-body FDG-PET imaging in the management of patients with cancerRoland Hustinx, François Bénard, Abass AlaviSeminars in Nuclear Medicine|October 17, 2018
Cognitive Impairment and DementiasMohsen Khosravi, Andrew Newberg, Abass AlaviRadiologic Clinics of North America|August 21, 2007
Critical role of 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplastyHongming Zhuang, Hua Yang, Abass AlaviHandbook of Clinical Neurology|July 20, 2016
Positron emission tomography: ligand imagingMateen Moghbel, Andrew Newberg, Abass AlaviRadiologic Clinics of North America|February 8, 2005
PET imaging in the assessment of normal and impaired cognitive functionDaniel H S Silverman, Abass AlaviPET Clinics|May 10, 2016
Role of Global Disease Assessment by Combined PET-CT-MR Imaging in Examining Cardiovascular DiseaseBabak Saboury, Pouya Ziai, Abass AlaviPageof 128